Xenetic Biosciences Inc Cash Flow-to-Debt Ratio
Xenetic Biosciences Inc cash flow-to-debt ratio. Xenetic Biosciences Inc (XBIO) has a Cash Flow-to-Debt Ratio of -0.98x as of June 2026, meaning its operating cash flow of $-875.49K could theoretically repay -1% of its total liabilities ($894.98K) in one year. Check Xenetic Biosciences Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Xenetic Biosciences Inc (2012–2025)
Cash flow-to-debt ratio of Xenetic Biosciences Inc from 2012 to 2025. Historical debt coverage capacity for Xenetic Biosciences Inc across 14 annual periods. Check Xenetic Biosciences Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Xenetic Biosciences Inc Cash Flow-to-Debt Ratio by Year (2012–2025)
Xenetic Biosciences Inc cash flow-to-debt ratio by year from 2012 to 2025. Year-by-year debt coverage analysis for Xenetic Biosciences Inc. For the full cash flow conversion analysis, see XBIO cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.36x | $-2.29 Million | $968.02K | ▲ +25.0% |
| 2024 | -3.15x | $-2.82 Million | $894.26K | ▲ +38.0% |
| 2023 | -5.08x | $-4.11 Million | $809.59K | ▼ -17.4% |
| 2022 | -4.33x | $-4.65 Million | $1.07 Million | ▼ -29.9% |
| 2021 | -3.33x | $-4.74 Million | $1.42 Million | ▲ +24.7% |
| 2020 | -4.43x | $-4.27 Million | $963.97K | ▼ -199.8% |
| 2019 | -1.48x | $-6.40 Million | $4.33 Million | ▼ -3.2% |
| 2018 | -1.43x | $-6.46 Million | $4.52 Million | ▼ -565.5% |
| 2017 | 0.31x | $1.49 Million | $4.86 Million | ▲ +116.8% |
| 2016 | -1.83x | $-8.79 Million | $4.80 Million | ▼ -255.4% |
| 2015 | -0.51x | $-5.30 Million | $10.30 Million | ▲ +75.6% |
| 2014 | -2.11x | $-12.33 Million | $5.84 Million | ▼ -139.1% |
| 2013 | -0.88x | $-6.05 Million | $6.85 Million | ▲ +35.2% |
| 2012 | -1.36x | $-6.26 Million | $4.59 Million | — |